| Model Number |
AVFM10100 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Cramp(s) /Muscle Spasm(s) (4521)
|
| Date of Event |
05/20/2021
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
As the lot number for the device was provided, a review of the device history records will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.(expiry date: 01/2023).
|
| |
|
Event or Problem Description
|
|
It was reported through the results of a clinical trial, post device implantation spasm of outflow vein was reported.The current patient status was not provided.
|
| |
|
Additional Manufacturer Narrative
|
|
H10: manufacturing review: a review of manufacturing records was not performed, as additional complaints have not been reported for this lot.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.However, the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: the returned sample analysis could not be performed as the physical device could not be possibly returned and no x-ray images were provided for evaluation.Therefore, the adverse event could not be confirmed.A definite root cause could not be determined.Labeling review: in reviewing the relevant labeling, it was found that the instructions for use of the covera vascular covered stent sufficiently address the potential complications and adverse events.The instructions for use further state 'potential complications may include, but are not limited to: thrombotic occlusion, restenosis requiring reintervention (.)'.Holding and handling of the system throughout deployment was found sufficiently described.Regarding the preparation of the device and the lesion, the instructions for use states: 'pre-dilate the stenosis with a pta balloon catheter of appropriate length and diameter for the lesion to be treated'.Moreover, the instructions for use states after stent deployment: ´'post dilate the covered stent with an angioplasty balloon sized appropriately as to ensure complete wall apposition to the reference vessel.Avoid balloon dilation in the healthy, non-stenosed segment of the vein.' h10: d4 (expiry date: 01/2023), g3.H11: h6 (method).H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
| |
|
Event or Problem Description
|
|
It was reported through the results of a clinical trial, post device implantation spasm of outflow vein was reported.The current patient status was not provided.
|
| |
|
Search Alerts/Recalls
|